Hatzis-Schoch Brent 4
4 · Black Diamond Therapeutics, Inc. · Filed Apr 13, 2021
Insider Transaction Report
Form 4
Hatzis-Schoch Brent
SEE REMARKS
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-04-12−179,915→ 164,552 totalExercise: $3.20Exp: 2029-06-11→ Common Stock (4,078 underlying) - Sale
Common Stock
2021-04-12$25.00/sh−4,078$101,950→ 8,400 total - Exercise/Conversion
Common Stock
2021-04-12$3.20/sh+4,078$13,050→ 12,478 total
Footnotes (2)
- [F1]Shares sold pursuant to a pre-established 10b5-1 trading plan effective as of June 12, 2020.
- [F2]25% of the shares subject to this option vested and became exercisable on May 22, 2020, with the remainder vesting in 36 equal monthly installments thereafter.